It is exciting that BRCA1 combined with STMN1 can also be used as a predictor for NSCLC patients.So, we recommend that the expression levels of BRCA1 and STMN1 should be detected before NSCLC patients received platinum and paclitaxel treatment. The gene discussed is STMN1; the disease is non-small cell lung carcinoma.